Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimate

Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel

1984 • 120 citations

Metabolic effects of oral contraceptives

1987 • 81 citations

Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes

1985 • 66 citations

Two oral contraceptives, efficacy, serum proteins, and lipid metabolism

1982 • 63 citations

Progestogens with antimineralocorticoid activity.

1985 • 62 citations

A randomized crossover comparison of two low-dose contraceptives: Effects on serum lipids and lipoproteins

1985 • 59 citations

On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral Contraceptives

1982 • 54 citations

New progestogens in oral contraceptives

1987 • 46 citations

Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel

1985 • 45 citations

Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions

1987 • 44 citations

Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.

1987 • 38 citations

Biotransformation of norgestimate in women

1984 • 31 citations

Clinical and metabolic effects of gestodene and levonorgestrel.

1987 • 30 citations

Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatment

1984 • 26 citations

Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.

1987 • 23 citations

Optimum dosage of an oral contraceptive

1979 • 23 citations

Advances in Fertility Control and the Treatment of Sterility

1984 • 23 citations

Changes in serum apo-lipoprotein AI and sex-hormone-binding globul in levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol

1984 • 22 citations

The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterus

1985 • 19 citations

The influence of the triphasic pill and a desogestrel-containing combination pill on some physical, biochemical and hormonal parameters: a preliminary report

1984 • 18 citations

Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.

1985 • 14 citations

Effects of 180 μg and 250 μg norgestimate on pituitary-ovarian function and cervical mucus

1988 • 11 citations

Gestoden, an innovative progestogen

1987 • 10 citations

Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus

1986 • 7 citations

Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.

1978 • 5 citations

Cited By (0)

Loading...